spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

CPhI & P-MEC India 2018

CPhI & P-MEC India

12-14 December 2018
India Expo Mart, New Delhi, India

CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part of Informa PLC) – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.

CPhI & P-MEC India comes with the backing of the Delhi-based Pharmaceuticals Export Promotion Council of India (Pharmexcil) – the organisation behind key Government international strategies such as ‘Made in India’. Mr. Yogesh Mudras, Managing Director, UBM India commented “the shift to the Delhi-NCR region, in close geographical proximity to the policy makers, consulates and government bodies will enhance our community building efforts, as well as the creation of a robust pharma eco-system.”

UBM cited rising international interest in the event as a key factor in the move, with numbers of both international and domestic exhibitors requiring a far bigger venue – and on single site.

Mr Mudras added “I am delighted that CPhI & P-MEC India will be held this year at India Expo Mart, Greater Noida – it’s the flagship platform for the Indian pharma industry and one of the world’s leading Pharmaceutical networking events. It’s also a major international hub, with India’s largest airport and this venue change is looking ahead to future audience needs.”

The venue change is also seen as a boost to domestically focused markets by bringing a wider remit of attendees and greater access to national regulatory pathways. The country registers the second largest Abbreviated New Drug Applications (ANDAs) globally and is the world’s leader in Drug Master Files (DMFs) applications so access to regulatory expertise has never been greater.

The 2018 edition will also feature India Pharma Week (returning for a third year), with unique events and activities spanning the Indian Capital. These include dynamic engagements such as the Pharma Leader’s Golf, Pharma Connect Congress, Plant Visits, Women in Pharma – Power Breakfast, India Pharma Awards, Networking Evening, and a closed-door CEO Roundtable amongst others.  

The ultimate goal of all these intertwined events is to help nurture a complete pharma ecosystem in India and better enable networking with the country’s corridors of power. In fact, the recent CPhI Pharma Index showed India represents global pharma’s second fastest growing market and praised the Delhi based regulator, the CDSCO (Central Drugs Standard Control Organization) for its efforts in introducing a certification programme and initiatives for increased compliance. Impressively, 52% of international respondents believed the CDSCO is moving toward comparability with the regulatory standards of the EMA and FDA.

For more information and to register for the event: https://www.cphi.com/india/

phone +31 20 708 1728
email cphicustomerservice@ubm.com
web https://www.cphi.com/india
email Delhi, India
 
Print this page
Send to a friend
   
spacer
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

White Papers

A Rules Based Approach to Labelling and Artwork Management

Kallik

Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >>


News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement